These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 33197126)

  • 21. Depigmentation Therapies for Vitiligo.
    Grimes PE; Nashawati R
    Dermatol Clin; 2017 Apr; 35(2):219-227. PubMed ID: 28317530
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Depigmentation during vitiligo activity spares epithelial grafted areas.
    Awad SS
    J Cosmet Dermatol; 2016 Dec; 15(4):383-386. PubMed ID: 27369365
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Can it make me white again? A case report of 88% phenol as a depigmenting agent in vitiligo.
    Mahmood F; Beach RA
    SAGE Open Med Case Rep; 2021; 9():2050313X21993307. PubMed ID: 33680467
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of different types of therapeutic trauma on vitiligo lesions.
    El Mofty M; Esmat S; Hunter N; Mashaly HM; Dorgham D; Shaker O; Ibrahim S
    Dermatol Ther; 2017 Mar; 30(2):. PubMed ID: 27998025
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Langerhans' cells in hair follicles of the depigmenting C57Bl/Ler-vit.vit mouse. A model for human vitiligo.
    Palkowski MR; Nordlund ML; Rheins LA; Nordlund JJ
    Arch Dermatol; 1987 Aug; 123(8):1022-8. PubMed ID: 2443080
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Demonstration of residual perifollicular pigmentation in localized vitiligo--a reverse and novel application of digital epiluminescence dermoscopy.
    Chuh AA; Zawar V
    Comput Med Imaging Graph; 2004 Jun; 28(4):213-7. PubMed ID: 15121210
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Laser treatment for further depigmentation in vitiligo.
    Thissen M; Westerhof W
    Int J Dermatol; 1997 May; 36(5):386-8. PubMed ID: 9199992
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Narrow-band UVB for the treatment of vitiligo: an emerging effective and well-tolerated therapy.
    Kanwar AJ; Dogra S; Parsad D; Kumar B
    Int J Dermatol; 2005 Jan; 44(1):57-60. PubMed ID: 15663664
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vitiligo nonsurgical treatment: a review of latest treatment researches.
    Zhang Y; Mooneyan-Ramchurn JS; Zuo N; Feng Y; Xiao S
    Dermatol Ther; 2014; 27(5):298-303. PubMed ID: 25041437
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The early repigmentation pattern of vitiligo is related to the source of melanocytes and by the choice of therapy: a retrospective cohort study.
    Yang K; Xiong X; Pallavi G; Ling Y; Ding F; Duan W; Sun W; Ding G; Gong Q; Zhu W; Lu Y
    Int J Dermatol; 2018 Mar; 57(3):324-331. PubMed ID: 29318595
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of stable and recalcitrant vitiligo by autologous miniature punch grafting: a prospective study of 1,000 patients.
    Malakar S; Dhar S
    Dermatology; 1999; 198(2):133-9. PubMed ID: 10325459
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fractional CO
    Al-Kady NA; Hamdino M; Abdel Kawy FAW
    J Cosmet Dermatol; 2021 Mar; 20(3):763-768. PubMed ID: 32892481
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Camouflage of Vitiligo by Medical Tattooing.
    Moreno A
    Curr Probl Dermatol; 2022; 56():187-196. PubMed ID: 37263205
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chronic actinic dermatitis with vitiligo-like depigmentation.
    von den Driesch P; Fartasch M; Hornstein OP
    Clin Exp Dermatol; 1992 Jan; 17(1):38-43. PubMed ID: 1424258
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Safety and Effectiveness of Decapeptide in Patients With Vitiligo: A Real-World Study.
    Sharma A; Majid I; Kumar HK; Banodkar P; Mhatre M; Mohod B; Jaiswal A
    Cureus; 2023 Jul; 15(7):e41418. PubMed ID: 37546028
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Depigmentation therapy with Q-switched ruby laser after tanning in vitiligo universalis.
    Kim YJ; Chung BS; Choi KC
    Dermatol Surg; 2001 Nov; 27(11):969-70. PubMed ID: 11737134
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oral manifestations of vitiligo.
    Nagarajan A; Masthan MK; Sankar LS; Narayanasamy AB; Elumalai R
    Indian J Dermatol; 2015; 60(1):103. PubMed ID: 25657420
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Laser-assisted depigmentation for resistant vitiligo: a retrospective case series with long-term follow-up.
    Boukari F; Lacour JP; Ortonne JP; Bahadoran P; Passeron T
    J Eur Acad Dermatol Venereol; 2014 Mar; 28(3):374-7. PubMed ID: 23167541
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Simultaneously active lesions of vitiligo and erythema dyschromicum perstans.
    Henderson CD; Tschen JA; Schaefer DG
    Arch Dermatol; 1988 Aug; 124(8):1258-60. PubMed ID: 3401033
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recalcitrant molluscum contagiosum in a patient with AIDS: combined treatment with CO(2) laser, trichloroacetic acid, and pulsed dye laser.
    Yoshinaga IG; Conrado LA; Schainberg SC; Grinblat M
    Lasers Surg Med; 2000; 27(4):291-4. PubMed ID: 11074505
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.